Focus area
Rare Disease Investment Firms
The RaiseHunt database lists 30 Rare Disease investment firms: 28 of them list a portfolio, 194 known investments between them and 79 people at those firms have a profile here. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in Boston, New York and Durham.
- 30
- Investment firms
- 28
- With a known portfolio
- 194
- Known investments
- 79
- People with a profile
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
30 Rare Disease investment firms
Showing 21-30
Filters
| Firm | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
HS Healthequity, SCR | Barcelona, Spain | Corporate VCVenture capital | Healthcare | View fund | |
CF Chiesi Farmaceutici | Amsterdam, Netherlands | Corporate VC | AIHealthcare | View fund | |
FM First Manhattan Consulting Group | New York, United States | Venture debt | Healthcare | View fund | |
CE Cure EB | London, United Kingdom | Government-backed | Healthcare | View fund | |
JP Jazz Pharmaceuticals | Tel Aviv, Israel | Corporate VC | Healthcare | View fund | |
TP Tanabe Pharma America | Boston, United States | Corporate VC | Healthcare | View fund | |
U Ultragenyx | Miami, United States | Corporate VC | Healthcare | View fund | |
MV Mitre Ventures | Venture capital | Healthcare | View fund | ||
CP Canaan Partners’ Axcelius | New York, United States | Venture capital | Healthcare | View fund | |
R Recordati | Biberach an der Riß, Germany | Corporate VC | Healthcare | View fund |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal